Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for post-stroke fatigue
ACTRN12615000350527Phase 2Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of modafinil in post-stroke fatigue (PSF) and fatigue after transient ischaemic attack (2 arms), sponsored by Hunter New England Local Health District. Primary endpoints: Self-reported fatigue and Physical activity. Started Jun 2015; status: completed.
02
Drugs
modafinil
03
Conditions
post-stroke fatigue (PSF)fatigue after transient ischaemic attack
Beyond the preview
Go deeper on ACTRN12615000350527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000350527.